{"id":52592,"date":"2021-07-30T10:34:00","date_gmt":"2021-07-30T10:34:00","guid":{"rendered":"https:\/\/www.verificat.cat\/medigen-comme-fonctionne\/"},"modified":"2021-07-30T10:34:00","modified_gmt":"2021-07-30T10:34:00","slug":"medigen-comme-fonctionne","status":"publish","type":"post","link":"https:\/\/www.verificat.cat\/fr\/medigen-comme-fonctionne\/","title":{"rendered":"Medigen"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>Ta&iuml;wan a autoris&eacute; le premier vaccin cr&eacute;&eacute; et mis au point sur l&rsquo;&icirc;le par<a href=\"https:\/\/www.medigenvac.com\/public\/en\" target=\"_blank\" rel=\"noopener\"> Medigen Vaccines Biologics Corp<\/a>, une entreprise biopharmaceutique locale, le vaccin ayant pour nom scientifique MVC-COV1901. Il s&rsquo;agit d&rsquo;une formule &agrave; base de<a href=\"https:\/\/www.verificat.cat\/infografia\/tipus-de-vacunes\" target=\"_blank\" rel=\"noopener\"> sous-unit&eacute;s prot&eacute;iques<\/a>, compos&eacute;e d&rsquo;<a href=\"https:\/\/www.medigenvac.com\/public\/en\/news\/detail\/78?from_sort=2\" target=\"_blank\" rel=\"noopener\">une version synth&eacute;tique de la prot&eacute;ine S<\/a> du SARS-CoV-2. En reconnaissant cette prot&eacute;ine comme un corps &eacute;tranger, l&rsquo;organisme produit des lymphocytes T et des anticorps qui garderont en m&eacute;moire la fa&ccedil;on dont lutter contre la covid-19 si l&rsquo;on est contamin&eacute; par la suite.<\/p>\n<p>Un essai clinique de<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04487210\" target=\"_blank\" rel=\"noopener\"> phase I<\/a> a &eacute;t&eacute; r&eacute;alis&eacute; sur 45 patients volontaires en vue d&rsquo;&eacute;valuer la s&eacute;curit&eacute; du vaccin. Selon les<a href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2021.03.31.21254668v1\" target=\"_blank\" rel=\"noopener\"> r&eacute;sultats publi&eacute;s<\/a>, la majorit&eacute; des effets secondaires &eacute;taient l&eacute;gers et similaires parmi les patients. Aucun effet secondaire grave n&rsquo;a &eacute;t&eacute; rapport&eacute;. Par la suite a eu lieu l&rsquo;essai de<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04695652\" target=\"_blank\" rel=\"noopener\"> phase II<\/a> comprenant 3700 volontaires et dont les<a href=\"https:\/\/www.medigenvac.com\/public\/en\/news\/detail\/78?from_sort=2\" target=\"_blank\" rel=\"noopener\"> r&eacute;sultats<\/a>, d&rsquo;apr&egrave;s l&rsquo;entreprise, ont confirm&eacute; la s&eacute;curit&eacute; du vaccin et la g&eacute;n&eacute;ration d&rsquo;anticorps neutralisants.<\/p>\n<p>Le<a href=\"https:\/\/www.medigenvac.com\/public\/en\/news\/detail\/83?from_sort=2\" target=\"_blank\" rel=\"noopener\"> vaccin a &eacute;t&eacute; autoris&eacute;<\/a> le 19 juillet &agrave; Ta&iuml;wan, avant que ne commence la troisi&egrave;me phase d&rsquo;essais cliniques, et en l&rsquo;absence de donn&eacute;es officielles sur son efficacit&eacute; face &agrave; la contamination symptomatique. La r&eacute;alisation d&rsquo;un essai clinique de phase III a &eacute;galement &eacute;t&eacute; approuv&eacute;e au Paraguay.<\/p>\n<p>Ce vaccin s&rsquo;administre en deux doses &agrave; un intervalle de 28 jours et doit &ecirc;tre stock&eacute; &agrave; une temp&eacute;rature comprise<a href=\"https:\/\/www.roc-taiwan.org\/uploads\/sites\/141\/2021\/06\/Newsletter_20210618_EN.pdf\" target=\"_blank\" rel=\"noopener\"> entre 2 et 8&ordm;C<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ta&iuml;wan a autoris&eacute; le premier vaccin cr&eacute;&eacute; et mis au  [&#8230;]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[170],"tags":[209],"class_list":["post-52592","post","type-post","status-publish","format-standard","hentry","category-non-classifiee","tag-vaccines-fr","vc-legacy-post"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/posts\/52592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/comments?post=52592"}],"version-history":[{"count":0,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/posts\/52592\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/media?parent=52592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/categories?post=52592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/tags?post=52592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}